SC 13G Filing

Company

AGIOS PHARMACEUTICALS, INC.

Filed

November 9, 2023

Accession Number

0000908834-23-000146

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →